天美传媒

Journal of Pharmacokinetics & Experimental Therapeutics
天美传媒 Access

Infliximab Pharmacokinetics

Search results for
Infliximab Pharmacokinetics

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Awards & Nominations
Publication Policies and Ethics
Citations : 14

Flyer image
Indexed In
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • Publons
  • ICMJE
View More
Useful Links
Share This Page

Infliximab Pharmacokinetics

Infliximab is used to treat rheumatoid arthritis, psoriatic arthritis and occasionally severe ankylosing spondylitis. Infliximab pharmacokinetic characteristics were similar in pediatric and adult patients with Crohn's disease or ulcerative colitis.

Journals Related to Infliximab Pharmacokinetics:

Journal of Pharmacokinetics & Experimental Therapeutics, , Drug Metabolism & Toxicology, Journal of Pharmacokinetics and Biopharmaceutics, Journal of Pharmacokinetics and Pharmacodynamics, Asian Journal of Pharmacodynamics and Pharmacokinetics.

Infliximab Pharmacokinetics

Expert PPTs

Speaker PPTs

  • Rinat Islamov
    Pharmacokinetics (PK) of anti-tuberculosis drug (FS-1) on healthy volunteers: results from the phase I trial
    | PDF Version
  • Viral Kansara
    Ocular melanin modulates pharmacokinetics and drug disposition of therapeutic agents
    | PDF Version
Conference Proceedings